Gene · 79718
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated expression of the EMX2OS/miR-34c-5p/TBL1XR1 regulatory axis: a novel signature for severe community-acquired pneumonia in children. | BMC Pediatr | 2026 | 42750020 | PubTator, text mining | PubMed |
| Nodal marginal zone lymphoma: genetic analysis and the differential diagnosis from other small B-cell lymphomas. | Blood Adv | 2026 | 42721462 | PubTator, text mining | PubMed |
| Expanding the TBL1XR1 Disease Spectrum: Generalized Dystonia Associated with a New Genetic Variant. | Tremor Other Hyperkinet Mov (N Y) | 2026 | 42699641 | PubTator, text mining | PubMed |
| A genome-wide map of the genetic network in monocytes that regulates type I interferon induction by the cGAS-STING pathway. | Sci Signal | 2026 | 42611972 | PubTator, text mining | PubMed |
| Erratum: [Corrigendum] TBL1XR1 as a potential therapeutic target that promotes epithelial-mesenchymal transition in lung squamous cell carcinoma. | Exp Ther Med | 2026 | 42577676 | PubTator, text mining | PubMed |
| Molecular Feasibility of Gene Sequencing on Lymph Node Fine-Needle Cytology Samples of Non-Hodgkin Lymphoma. | Int J Mol Sci | 2026 | 42450228 | PubTator, text mining | PubMed |
| TBL1XR1 mutations promoted tumor progression in diffuse large B-cell lymphoma through impairing nature killer cytotoxicity via the MYC-CD47/PD-L1 axis. | Mol Cancer | 2026 | 42436518 | PubTator, text mining | PubMed |
| Kidney failure in a child with Pierpont syndrome: a case report highlight challenges in kidney replacement therapy. | BMC Nephrol | 2026 | 42365304 | PubTator, text mining | PubMed |
| A Novel De Novo Frameshift Variant of TBL1XR1 Leads to Neurodevelopmental Disorders and Treatment Experience. | Int J Dev Neurosci | 2026 | 42281549 | PubTator, text mining | PubMed |
| Dysfunction of a SET3-like complex underlies a family of related neurological disorders. | Nat Commun | 2026 | 42143056 | PubTator, text mining | PubMed |
| TBL1X/TBL1XR1 govern β-cell identity through a PAX6-containing gene regulatory network. | Nat Commun | 2026 | 42020373 | PubTator, text mining | PubMed |
| Identification of plasma exosome circRNA as potential novel biomarkers for DLBCL and circrna-miRNA-mRNA network analysis. | Clin Exp Med | 2026 | 41925757 | PubTator, text mining | PubMed |
| Germ layer specification and organotropism in lymphoma invasion. | Sci Bull (Beijing) | 2026 | 41904054 | PubTator, text mining | PubMed |
| New Cyclopeptides and Curvularins from Marine-Derived Fungal-Bacterial Symbiont Aspergillus spelaeus GXIMD 04541/Sphingomonas echinoides GXIMD 04532. | Mar Drugs | 2026 | 41892970 | PubTator, text mining | PubMed |
| 1-(4-Bromo-phen-yl)-4,5-diphenyl-2-(1H-pyrrol-2-yl)-1H-imidazole. | IUCrdata | 2026 | 41799325 | PubTator, text mining | PubMed |
| A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia. | Ann Med | 2026 | 41797694 | PubTator, text mining | PubMed |
| Histone chaperone CHAF1B facilitates germinal center B cell differentiation via cooperation with BCL6 and TBL1XR1. | J Immunol | 2026 | 41764732 | PubTator, text mining | PubMed |
| CDX2 Expression and Fluoropyrimidine Response in Rare Non-GI Tumors: A Three-Case Series. | Curr Oncol | 2026 | 41744890 | PubTator, text mining | PubMed |
| Structural modeling and functional characterization of a novel gain-of-function TLR8 variant causing severe inflammatory syndrome. | JCI Insight | 2026 | 41729082 | PubTator, text mining | PubMed |
| Combination of serum TBL1XR1, MFAP5, and PSA as diagnostic biomarkers for prostate cancer. | Clinics (Sao Paulo) | 2026 | 41666500 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79718/papers